Cabergoline: Clinical Trials

12 trials of Cabergoline, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 enrolling by invitation, 1 not yet recruiting, 1 recruiting. 12 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 412Completed 6, Enrolling by invitation 2, Not yet recruiting 1, Recruiting 1, Terminated 1, Unknown 1

Follow Cabergoline: new trials by email Literature Review of Cabergoline trials Research Report on Cabergoline

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combination Osilodrostat and Cabergoline in Cushing's Disease
osilodrostat, osilodrostat and cabergoline - Cushing Disease Due to Increased ACTH Secretion
Phase 4Enrolling by invitationUniversity of Basrah502026-05-112026-05-22
Carbergoline for Antipsychotic Induced Hyperprolactinemia.
Cabergoline (Dopamine Agonist), Placebo - Scizophrenia
Phase 4Not yet recruitingZealand University Hospital1462026-05-012026-02-04
Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist Treatment
Cabergoline (Dopamine Agonist) - Prolactinoma
Phase 4RecruitingUniversity Hospital, Basel, Switzerland602025-09-162025-09-23
Cabergoline in the Management of Nonfunctioning Pituitary Adenoma
Cabergoline 0.5 MG - Pituitary Adenoma, MRI
Phase 4Enrolling by invitationNational Taiwan University Hospital302024-05-202025-06-24
Pharmacological Inhibition of Lactation After 16 to 20 Week Abortion
Cabergoline, Placebo - Lactation Suppressed, Second Trimester Abortion
Phase 4CompletedNorthwestern University152023-12-182026-10-15
Cabergoline Before or After Oocyte Collection for Follicular Resolution
Cabergoline Pill - Infertility, Female
Phase 4CompletedFertility Center of Las Vegas702019-09-232021-06-14
Value of Cabergoline and Low Dose Aspirin in Poor Responders Undergoing ICSI-ET With GnRH Agonist Flare-Up-Protocol
cabergoline, Aspirin, GnRH agonist - Invitro Fertilization
Phase 4UnknownCairo University1202017-08-012017-08-28
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies
Pasireotide, Cabergoline, Pasireotide LAR - Cushing's Disease, Acromegaly
Phase 4CompletedRECORDATI GROUP3372013-06-102024-10-01
Study to Evaluate the Efficacy and Safety of Sandostatin LAR at High Dose or in Combination Either With GH-receptor Antagonist or Dopamine-agonist in Acromegalic Patients
Sandostatin LAR, pegvisomant, cabergoline - Acromegaly
Phase 4CompletedNovartis Pharmaceuticals702006-09-012017-03-03
Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly
Octreotide acetate and cabergoline/Octrotide and Somavert - Acromegaly
Phase 4CompletedNovartis Pharmaceuticals202006-03-012017-03-06
Dopamine Turnover Rate as Surrogate Parameter for Diagnosis of Early Parkinson's Disease
Cabergoline, Levodopa - Parkinson's Disease
Phase 4CompletedTechnische Universität Dresden392005-02-012012-12-18
Study Of Cabaser and Sinemet CR For The Treatment Of Nighttime Symptoms Associated With Parkinson's Disease.
cabergoline, controlled-release levodopa / carbidopa - Parkinson Disease
Phase 4TerminatedPfizer2202004-07-012007-05-25

Conditions studied

Acromegaly (3)  ·  Pituitary Neoplasms (3)  ·  Parkinson Disease (2)  ·  Pituitary ACTH Hypersecretion (2)  ·  Adrenal Insufficiency (1)  ·  Brain Neoplasms (1)  ·  Dumping Syndrome (1)  ·  Hyperandrogenism (1)  ·  Hyperprolactinemia (1)  ·  Hypertension (1)  ·  Hypokalemia (1)  ·  Infertility, Female (1)  ·  Melanoma (1)  ·  Neoplasms (1)  ·  Neuroendocrine Tumors (1)

Sponsors

Novartis Pharmaceuticals (2)  ·  Cairo University (1)  ·  Fertility Center of Las Vegas (1)  ·  National Taiwan University Hospital (1)  ·  Northwestern University (1)  ·  Pfizer (1)  ·  RECORDATI GROUP (1)  ·  Technische Universität Dresden (1)  ·  University Hospital, Basel, Switzerland (1)  ·  University of Basrah (1)  ·  Zealand University Hospital (1)

Countries

Germany (3)  ·  Italy (3)  ·  Switzerland (3)  ·  United States (3)  ·  France (2)  ·  Poland (2)  ·  Portugal (2)  ·  Spain (2)  ·  Taiwan (2)  ·  Argentina (1)  ·  Australia (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Canada (1)

Top investigators

Abbas A Mansour (1)  ·  Ahmed Maged, MD (1)  ·  Bruce Shapiro, MD (1)  ·  Cihan Atila, Dr. (1)  ·  Haider A Alidrisi (1)  ·  Heinz Reichmann, MD (1)  ·  Ibrahim H Hussein, MD (1)  ·  Jesper Krogh (1)

Results publications

PMID 21553090

NIH funding

2005 (1), 2025 (1)